I Want To...
Find a Doctor
Find a doctor at The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center or Johns Hopkins Community Physicians.
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Promise and Progress - JHU Engineering Student Invents Melanoma Screening Device
The Time is Now: 2010-2011
JHU Engineering Student Invents Melanoma Screening Device
Date: November 11, 2010
March 26, 2010
Muge Pirtini, M.S., a Johns Hopkins mechanical engineering student, was selected as one of Baltimore's "10 to Watch Under 30." Under the tutelage of Cila Herman, Ph.D., professor of mechanical engineering at the Johns Hopkins University and a special camera provided by the Johns Hopkins Applied Physics Laboratory, Pirtini helped develop a thermal sensor to distinguish melanoma from non-melanoma.
“The problem with diagnosing melanoma in the year 2010 is that we don’t have any objective way to diagnose this disease,” said Rhoda Alani, M.D., adjunct professor at the Johns Hopkins Kimmel Cancer Center and professor and chair of Dermatology at the Boston University School of Medicine. Doctors look for moles and subjective clues such as size, shape and coloring. “Our goal is to give an objective measurement as to whether a lesion may be malignant. It could take much of the guesswork out of screening patients for skin cancer.”
Melanoma is an aggressive and lethal form of skin cancer, but when diagnosed early, it is very treatable. Pirtini’s method uses a noninvasive infrared scanning system to detect the slight temperature differences that exist between healthy tissue and a growing tumor, allowing doctors to distinguish a harmless mole from a deadly melanoma.
Because cancer cells divide more rapidly than normal cells, they typically generate more metabolic activity and release more energy as heat. To detect this, Herman uses a highly sensitive infrared camera on loan from the Applied Physics Lab. Normally, the temperature difference between cancerous and healthy skins cells is extremely small, so Herman and Pirtini devised a way to make the difference stand out. First, they cool a patient’s skin with a harmless one-minute burst of compressed air. When the cooling is halted, they immediately record infrared images of the target skin area for two to three minutes. Cancer cells typically reheat more quickly than the surrounding healthy tissue, and this difference can be captured by the infrared camera and viewed through sophisticated image processing.
A pilot study of 50 patients is currently underway and will help investigators begin to refine the technology to ensure it specifically and accurately identifies melanomas and precancerous lesions. The end product the investigators envision is a hand-held device. Dermatologists could use it to evaluate suspicious mole and could be incorporated into a full-body-scanning system for patients with a large number of pigmented lesions.
There is much more work to be done, say the researchers. “We need to fine-tune the instrument—the scanning system and the software—and develop diagnostic criteria for cancerous lesions,” says Herman. “When the research and refinement are done, we hope to be able to show that our system can find melanoma at an early stage before it spreads and becomes dangerous to the patient.”
The discovery was funded by the National Science Foundation.
Articles in this Issue
Cover Story: Personalized Medicine is Here, The Time is Now
- Personalized Medicine is Here: The Time is Now
- Cover Story Sidebar: Our Cancer Research is Curing Other Diseases Too
- Cover Story Sidebar: A New Paradigm for Cancer Drug Discovery
- Cover Story Sidebar: Personalized Approaches in Pediatric Cancer
- Cover Story Sidebar: The Frankenstein Project
- Cover Story Sidebar: The Serendipitous Discovery of a Cancer Starter
- Cover Story Sidebar: The Mathematics of Curing Cancer
- Immune Cell Commander
- A Personalized Genetic Profile for Brain Cancer
- A New "Twist" in Breast Cancer
- JHU Engineering Student Invents Melanoma Screening Device
- Special Delivery: Biodegradable Particles Transport Drugs to Diseased Tissues and Organs
- Targeting Brain Cancer Stem Cells
- Vaccine Clears Out Leukemia Cells
- Does Low Cholesterol Equal Lower Risk of High-Grade Prostate Cancer?
- A Common Good - The Commonwealth Foundation
- Helping Us Solve The Cancer Puzzle
- The Skip Viragh Center
- Making Waves to Fight Cancer
- Gift Brings Complementary Care to Cancer Patients
- A Major Gift for Kidney Cancer Research
- Giant Food Supports Childhood Cancer Research
- Wawa Cares About Cancer Patients
- Young Lacrosse Players Faced Off Against Childhood Cancer